Human medicine European public assessment report (EPAR): Carmustine medac (previously Carmustine Obvius) (updated)

carmustine, Hodgkin Disease; Lymphoma, Non-Hodgkin
Date of authorisation: 18/07/2018, , Revision: 8, Authorised, Last updated: 14/09/2023